Bridge

Leslie Leinwand, "Myosin myopathies: Mechanisms of pathogenesis and potential therapeutics"

Prof. Leslie Leinwand received her PhD in 1978 from Yale University and did post-doctoral training at Rockefeller University. In 1981, she joined the faculty at Albert Einstein College of Medicine in New York until 1995, when she moved to Colorado as Chair of Molecular, Cellular, and Developmental Biology (MCDB). Currently, Prof. Leinwand is a Distinguished Professor and Faculty Director of MCDB at the BioFrontiers Institute at the University of Colorado, Boulder. Her research focuses on how cardiac and skeletal muscle adapt to stimuli, particularly the pathways involved in heart enlargement in response to exercise and disease. Her goal is to translate her lab’s research findings – from the fundamental understanding of the myosin motors and how mutations in them cause disease to the investigation of sex differences in cardiac physiology – to improve human health and disease. Prof. Leinwand has co-founded different companies, most recently MyoKardia, Inc, a publicly traded company founded to develop therapeutics for inherited cardiomyopathies. Her teaching was recognized by funding from the Howard Hughes Medical Institute’s Professor Program, and she was recently elected to the American Academy of Arts and Sciences and the National Academy of Inventors. For more information, please visit her lab at https://www.colorado.edu/lab/leinwand/

Venue

Robert-Rössle-Str. 10
Max Delbrück Communications Center
13125 Berlin
Germany

Time

-
MDC.C

Organizers

Michael Gotthardt
Group Leader

Neuromuscular and Cardiovascular Cell Biology
MDC


Further events